Discharge Planning TB
Discharge Planning TB
Discharge Planning TB
Date TB therapy initiated: / / Interruption in therapy? 䡺 Yes 䡺 No If yes, state the reason and duration
mm dd yyyy
of the interruption?
TB medications 䡺 INH _____ mg 䡺 RIF _____ mg 䡺 PZA _____ mg 䡺 EMB _____ mg 䡺 SM _____ mg 䡺 Vitamin B6 _____ mg
at discharge:
䡺 Injectables (specify) 䡺 Other TB meds (specify)
Frequency: 䡺 Daily 䡺 2x weekly 䡺 3x weekly 䡺 Other
Was a central line (i.e. PICC) inserted on the patient? 䡺 Yes 䡺 No
Number of days of medications supplied to patient at discharge Patient agreed to be on DOT? 䡺 Yes 䡺 No
TB 354 (11/10)
Guidelines for How to Complete and Submit the Mandatory TB
Hospital Discharge Approval Request Form (TB 354)
As of June 16, 2010, Article 11 of the New York City Health Code mandates health care providers to obtain approval
from the New York City Department of Health & Mental Hygiene (DOHMH) before discharging infectious TB patients
from the hospital.
Instructions for Completing the Hospital Discharge Approval Request Form (TB 354)
Section A Patient contact information: Provide the patient’s contact information including patient’s name, a verified
address and telephone numbers. In addition, include a name of an emergency contact, the contact’s relationship to
the patient and the contact’s verified phone number.
Section B Discharge information: Provide the name and phone number of the discharging facility, the medical
record number of the patient at the facility, date the patient was admitted, planned discharge date, and the location
to which the patient is being discharged. If the patient will be discharged to a location other than the patient’s
address listed in Section A, a facility name (if applicable), address and phone number must be provided. If the patient
plans to travel, provide the date and destination.
Section C Patient follow-up appointment: Provide the patient’s follow-up appointment date, as well as the name
and contact information of the provider who is assuming patient care. Check all potential obstacles that may affect
TB therapy adherence.
Section D Laboratory results: Report the results of the three most recent acid fast bacilli (AFB) smears including the
date of specimen collection, specimen source, and AFB smear results and/or grade.
Section E Treatment information: Fill in the date TB treatment was initiated. If there were any treatment
interruptions, indicate the reason and number of days treatment was stopped. Check the box next to each
prescribed drug and state dosages for each drug. Write in drugs and dosages for drugs not specified. Specify the
treatment frequency by checking one of the three boxes, or writing in a different treatment schedule. State whether
the patient will have a central line inserted at the time of discharge. If TB medication will be supplied to the patient at
discharge, write the number of days for which the medication will be supplied. State whether the patient agreed to be
on directly observed therapy (DOT).
After Section E, the name of the person completing the form should be printed and the authorized physician at the
discharging facility must print and sign their name, and provide their medical license number and telephone number.
TB 354 (11/10)